# Tear Film Innovations iLux Safety Study

> **NCT03055897** · NA · COMPLETED · sponsor: **Tear Film Innovations, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Meibomian Gland Dysfunction
- Evaporative Dry Eye

## Interventions

- **DEVICE:** iLux 2020 System

## Key facts

- **NCT ID:** NCT03055897
- **Lead sponsor:** Tear Film Innovations, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-03
- **Primary completion:** 2016-05-17
- **Final completion:** 2016-05-18
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055897, "Tear Film Innovations iLux Safety Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03055897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*